Drawing for THYTREG

USPTO serial 79375552

THYTREG

Reviewed by CopyMark Law Group

Reg. 7616715Status 700Registered
Filing date
Status date
Registration date
Dec 24, 2024
Examiner
KRUSSMAN, IAN GEORGE
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with THYTREG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashford Tucker

Ashford Tucker Fross Zelnick Lehrman & Zissu, P.C.151 W 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of immune system related and inflammatory diseases and disorders; immune-system [ regulator agents ] * therapeutic cellular preparations * being regulatory T cells for medical purposesACTIVE—
042Technological and scientific research services in cell population separation; Technological and scientific research services in cell population separation aimed at controlling and modulating the immune system; information services and data services in the nature of providing medical and scientific research information and compiling data for research purposes in the field of medical science and medical consultancy, both regarding medical research and developmentACTIVE—
044Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes related to the treatment of patients; medical immunological analyses relating to the treatment of patients; cell therapy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 5, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 1, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jun 12, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 12, 2025LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jun 12, 2025FIMPFINAL DISPOSITION PROCESSED—
Jun 12, 2025COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jun 12, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 24, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 17, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 1, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 1, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 24, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 24, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 22, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 22, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 2, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 13, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 12, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 12, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 8, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 16, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 16, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 16, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 24, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 23, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2024DOCKASSIGNED TO EXAMINER—
Aug 8, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 4, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance